Widemann, Brigitte
- Division of Basic Sciences - Nci (no department on record)
- Division of Clinical Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #420
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#420
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Widemann, Brigitte as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC011852-06ZIAContact PIMyPART: My Pediatric and Adult Rare Tumor Network - Cures$5.4Maward amount
- 1ZIASC010354-24ZIAContact PITherapies for patients with rare tumors and genetic tumor predisposition$1.9Maward amount
Award organizations
Organizations that administered FY2023 awards listing Widemann, Brigitte as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardDivision of Basic Sciences - Nci
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #5339
- 2008Multi-Institutional ResearchAwards at 2 institutions
- 2009$2M Cumulative Funding
- 2010Entered Top 25% NationallyRanked #3834
- 2011$5M Cumulative Funding
- 2013$10M Cumulative Funding
- 2021$25M Cumulative Funding
- 2021Entered Top 10% NationallyRanked #58
- 2021Entered Top 5% NationallyRanked #58
- 2021Entered Top 1% NationallyRanked #58
- 2023$50M Cumulative Funding